🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Proud of this paper by ⁦superstar #nsurg resident ⁦Tej D. Azad 🇺🇸⁩, and amazing ⁦Hopkins Business of Health Initiative⁩ collaborators ⁦Kelly Anderson⁩ ⁦@EconDarden⁩ Osteoporosis testing and treatment remain low in both Traditional Medicare and Medicare Advantage link.springer.com/article/10.100…

In this cohort study using data from the Colorado All Payer Claims Database (2018-2022), community pharmacy closures were associated with significant reductions in anticonvulsant prescription fills and days' supply. ja.ma/4gfokbS

So refreshing to see a reduction instead of increase in conference registration fees! Wish other health policy conferences would follow a similar approach and look strategically at their budgets

The market for compounded GLP-1s for weight loss exploded in the past few years due to high demand and shortages of drugs like Ozempic and Wegovy. In a recent paper, we describe the availability of these compounded products in Colorado. Link below! CU Pharmacy Kavita Nair

There is a push for Pharmacy Benefit Manager (PBM) reform under the guise of protecting retail pharmacy. Some policy proposals are warranted - but there are pressures for retail pharmacies that we are failing to include in this conversation. (1/7) statnews.com/2025/01/15/pha…

In STAT Joey Mattingly and I discuss the complexities of supporting community pharmacies

Four years ago I wrote my inaugural poem The Hill We Climb. Both when I wrote it and performed it, I did so while continuously reflecting on Dr. Martin Luther King Jr and Coretta Scott King’s legacy. I was (and am) blown away by how my words reverberated around the world; if

Meet the panelists for Johns Hopkins Bloomberg School of Public Health's International Conference on Drug Pricing and Affordability: Panel 1 Diego Ocampo from Neolpharma Prashant Yadav (@prof-yadav.bsky.social) from Council of Foreign Relations Katherine .E. Bliss from CSIS Global Health (See more in replies.)

More on tomorrow’s conference . The panels will be 🔥

New paper out with Matthew Eisenberg at Journal of Risk and Insurance titled "Banding together to lower the cost of health care? An empirical study of the Peak Health Alliance in Colorado." Johns Hopkins Bloomberg School of Public Health onlinelibrary.wiley.com/doi/full/10.11…

In JAMA Network Open #StanMathis builds a measure of community vulnerability to pharmacy closure. Joey Mattingly and I had the pleasure of writing a commentary about this awesome paper and how it builds upon pharmacy desert research jamanetwork.com/journals/jaman… jamanetwork.com/journals/jaman…

In their new Forefront article, David Anderson and Kelly Anderson from University of South Carolina and CU Pharmacy discuss how CMS should monitor the effect on Medicare standalone prescription drug plans of changes in how the drug costs of high-cost enrollees are split between the federal government

On a kick of listening to albums undistracted when I’m on airplanes vs trying to work (still trying to work in airports). Recommendations please! Old or new

Congratulations to Michael DiStefano, Kavita Nair, Gina Moore, and Joseph Saseen on being selected for the 2025 cohort of #NIHCM Research Grantees! Read more in the release: bit.ly/ResGr25 | #NIHCMGrants2025

Excited to get this brand new book by Jerry Avorn from Program On Regulation, Therapeutics, And Law in the mail today! Can't wait to give it a read! Brigham and Women's Hospital Harvard Medical School

Health Affairs Scholar #HAScholar Health Affairs is delighted to publish today interviews with 2 "giants" in health policy: Rob Califf @robcaliff.bsky.social and Mark McClellan Duke-Margolis @dukemargolis.bsky.social.

Happy to have been able to help out with new research led by Ian Liu, with co-authors Ameet Sarpatwari and Aaron Kesselheim (Program On Regulation, Therapeutics, And Law). We looked at trials, labelling changes, and revenues associated with the Best Pharmaceuticals for Children Act. sciencedirect.com/science/articl…